ºÐ°ú | ½Ã°£ | ±³À°ÁÖÁ¦ | ¼Ò¼Ó | °»ç¸í |
³»ºÐºñ ´ë »ç |
°©»ó¼± ÁúȯÀÇ ÃÖ½ÅÁö°ß | <ÁÂÀå: À̱¤¿ì¤ýÃÖµ¿¼·> |
|
09:00~09:40 |
ÀÏÂ÷Áø·á¿¡¼ ½ÃÇàÇÏ´Â °©»ó¼±±â´É°Ë»çÀÇ Çؼ® |
Àü³²ÀÇ´ë |
°È£Ã¶ |
09:40~10:20 |
±×·¹À̺꽺º´ÀÇ ÀûÀýÇÑ Ä¡·á¹ý ¼±Åà |
°í½ÅÀÇ´ë |
ÃÖ¿µ½Ä |
10:20~10:40 |
Coffee break |
10:40~11:20 |
°©»ó¼±¾ÏÀÇ molecular pathogenesis |
¿øÀڷº´¿ø |
ÀÌ°¡Èñ |
11:20~12:00 |
°©»ó¼± ºÐȾÏÀÇ Ä¡·á°³¿ä (2007³â ¿ì¸®³ª¶ó Ä¡·á ±Ç°í¾È ±Ù°Å) |
¿ï»êÀÇ´ë |
±èÅ¿ë |
Ç÷¾× Á¾¾ç |
Supportive care in cancer treatment | <ÁÂÀå: Çö¸í¼ö> |
|
09:00~09:25 |
Antiemetics |
¿ï»êÀÇ´ë |
ÀÌÀç·Ã |
09:20~09:50 |
Growth factor |
¿¬¼¼ÀÇ´ë |
±èÁø¼® |
09:50~10:15 |
Nutritionalsupport |
Ãæ³²ÀÇ´ë |
À±È¯Áß |
10:15~10:40 |
Psychologic support |
¼¿ïÀÇ´ë |
ÇÔºÀÁø |
10:40~11:00 |
Coffee break |
How I treat cnacer | <ÁÂÀå: ±è½Ã¿µ> |
|
11:00~11:30 |
Breast cancer |
¼º±Õ°üÀÇ´ë |
ÀÓ¿µÇõ |
11:30~12:00 |
Acute lymphoblastic leukemia |
°¡Å縯ÀÇ´ë |
ÀÌ ¼® |
°¨ ¿° |
°èÀý¼º °¨¿°Áúȯ | <ÁÂÀå: ¹èÇöÁÖ> |
|
09:00~09:40 |
ºñºê¸®¿À °¨¿°Áõ |
Á¶¼±ÀÇ´ë |
±èµ¿¹Î |
09:40~10:20 |
ÂêÂê°¡¹«½Ãº´ |
Ãæ³²ÀÇ´ë |
±è¿¬¼÷ |
10:20~10:40 |
Coffee break |
<ÁÂÀå: ±è¹ÎÀÚ> |
10:40~11:20 |
½ÅÁõÈıº ÃâÇ÷¿ |
¿øÁÖÀÇ´ë |
±èÈ£¿ |
11:20~12:00 |
·¾Å佺ÇÇ¶óº´ |
°æºÏÀÇ´ë |
ÀåÇöÇÏ |
¾Ë·¹ ¸£±â |
Update on diagnosis and treatment of allergic diseases <ÁÂÀå: ¹ÚÃá½Ä> |
|
09:00~09:30 |
Virus as the origin of asthma? |
¼øõÇâÀÇ´ë |
ÀÌ¿µ¸ñ |
09:30~10:00 |
Churg-Strauss syndrome |
¼º±Õ°üÀÇ´ë |
ÃÖµ¿Ã¶ |
10:00~10:30 |
Exhaled NO measurement for asthma |
ÇѾçÀÇ´ë |
À±È£ÁÖ |
10:30~11:00 |
Coffee break |
11:00~11:30 |
Korean experience of drug adverse reaction monitoring |
¿¬¼¼ÀÇ´ë |
¹ÚÁß¿ø |
11:30~12:00 |
Does lung image studies have role in asthma? |
¼¿ïÀÇ´ë |
Á¶»óÇå |
·ù¸¶ Ƽ½º |
Update on the rheumatic diseases | <ÁÂÀå: ¹Ú¼ºÈ¯> |
|
09:00~09:20 |
Introduction |
°¡Å縯ÀÇ´ë |
¹Ú¼ºÈ¯ |
09:20~10:20 |
EBV and SLE |
¿¹ÀÏÀÇ´ë |
°Àμö |
10:20~10:40 |
Coffee break |
10:40~11:20 |
The role of CRP in SLE |
Àü³²ÀÇ´ë |
À̽ż® |
11:20~12:00 |
Glucocorticooids: action and new therapeutic insights in RA |
ºÎ»êÀÇ´ë |
±è¼ºÀÏ |